Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nicotinic Modulation of the Default Network of Resting Brain Function

NCT01223404 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT01223404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01223404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nicotinic Modulation of the Default Network of Resting Brain Function
Lead sponsor
University of Maryland, Baltimore
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2010
Completion date
September 30, 2013
Enrollment
21 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cognition, magnetic resonance imaging, mecamylamine, nicotine